FindTrial
Sign In

Application of improved transperineal template-guided prostate biopsy in the diagnosis of prostate cancer

Application of improved transperineal template-guided prostate biopsy in the diagnosis of prostate cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900025284
Enrollment
Unknown
Registered
2019-08-21
Start date
2017-06-01
Completion date
Unknown
Last updated
2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

observation group:improved transperineal template-guided prostate biopsy
Control group:Traditional methods

Sponsors

Northern Jiangsu People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
42 Years to 85 Years

Inclusion criteria

Inclusion criteria: digital rectal examination findings nodules; and/or ultrasound or magnetic resonance imaging revealings suspicious of prostate cancer; and/or PSA4 ~ 10 ng/ml with an abnormal free/total PSA or PSA density; and/or PSA >10 ng/ml.

Exclusion criteria

Exclusion criteria: previous prostate biopsies,bleeding disorder, pathological rectum, active urinary tract infection

Design outcomes

Primary

MeasureTime frame
positive rates;—

Countries

China

Contacts

Public ContactDing Xue-fei

Northern Jiangsu People's Hospital

xuefeid@126.com+86 18051061234

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026